These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35729577)

  • 1. GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients.
    Zeng J; Wu H; Liu D; Li L; Li J; Wang Q; Ye M; Huang Q; Yu Z; Zhang J
    World J Surg Oncol; 2022 Jun; 20(1):212. PubMed ID: 35729577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
    Romero A; Martín M; Oliva B; de la Torre J; Furio V; de la Hoya M; García-Sáenz JA; Moreno A; Román JM; Diaz-Rubio E; Caldés T
    Ann Oncol; 2012 Jul; 23(7):1750-6. PubMed ID: 22052985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms in Glutathione S-Transferase (GST) Gene and Their Correlation with Toxicity of Chemotherapy in Breast Cancer Patients.
    Gudur RA; Bhosale SJ; Gudur AK; Datkhile KD
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2271-2282. PubMed ID: 39068558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach.
    Tulsyan S; Chaturvedi P; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B
    Mol Diagn Ther; 2013 Dec; 17(6):371-9. PubMed ID: 23812950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
    Kong X; Li Z; Li X
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1163-1173. PubMed ID: 27785604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.
    Sugishita M; Imai T; Kikumori T; Mitsuma A; Shimokata T; Shibata T; Morita S; Inada-Inoue M; Sawaki M; Hasegawa Y; Ando Y
    Breast Cancer; 2016 Mar; 23(2):195-201. PubMed ID: 25008867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer.
    Ferracini AC; Lopes-Aguiar L; Lourenço GJ; Yoshida A; Lima CSP; Sarian LO; Derchain S; Kroetz DL; Mazzola PG
    Clin Transl Sci; 2021 Mar; 14(2):720-728. PubMed ID: 33326171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients.
    Ji M; Tang J; Zhao J; Xu B; Qin J; Lu J
    Cancer Biol Ther; 2012 Mar; 13(5):264-71. PubMed ID: 22310978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase P1 gene polymorphisms and susceptibility to coronary artery disease in a subgroup of north Indian population.
    Bhat MA; Gandhi G
    J Genet; 2017 Dec; 96(6):927-932. PubMed ID: 29321351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms.
    Deng X; Hou J; Deng Q; Zhong Z
    World J Surg Oncol; 2020 Dec; 18(1):321. PubMed ID: 33280607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of GSTP1 p.Ile105Val (rs1695, c.313A > G) Variant with the Risk of Breast Carcinoma among Egyptian Women.
    Youssef MM; Elsaid AM; El-Saeed RA; Mukhlif RT; Megahed H; Al-Alawy AI; Elshazli RM
    Biochem Genet; 2021 Dec; 59(6):1487-1505. PubMed ID: 33939082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment.
    Zárate R; González-Santigo S; de la Haba J; Bandres E; Morales R; Salgado J; Gómez A; Aranda E; García-Foncillas J
    Curr Drug Metab; 2007 Jun; 8(5):481-6. PubMed ID: 17584018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of polymorphisms of AhR -1661G/A with GSTP1 -313A/G and susceptibility to endometriosis].
    Wang YF; Zong LL; Mao T; Wang YF; Fu YG; Zeng J; Rao XQ
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):522-5. PubMed ID: 23141164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum-induced ototoxicity in pediatric cancer survivors: GSTP1 c.313A>G variant association.
    Sherief LM; Rifky E; Attia M; Ahmed R; Kamal NM; Oshi MAM; Hanna D
    Medicine (Baltimore); 2022 Nov; 101(45):e31627. PubMed ID: 36397425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of drug metabolism enzymes (GSTM1, GSTT1 and GSTP1) in the healthy Malian population.
    Kassogue Y; Diakite B; Kassogue O; Konate I; Tamboura K; Diarra Z; Dehbi H; Nadifi S; Traore CB; Dao S; Doumbia S; Dolo G
    Mol Biol Rep; 2020 Jan; 47(1):393-400. PubMed ID: 31650384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the role of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicities.
    Gong JY; Peng SY; Xing K; Fan L; Tan SL; Luo ZY; Yuan HY; Xu P; Luo JQ
    Medicine (Baltimore); 2021 Mar; 100(11):e24423. PubMed ID: 33725933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study.
    van Ramshorst MS; van Werkhoven E; Honkoop AH; Dezentjé VO; Oving IM; Mandjes IA; Kemper I; Smorenburg CH; Stouthard JM; Linn SC; Sonke GS;
    Breast; 2016 Oct; 29():153-9. PubMed ID: 27498129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy.
    Zhou X; Wang X; Song Q; Yang H; Zhu X; Yu J; Song G; Di L; Ren J; Shao H; Lyerly HK
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):914-22. PubMed ID: 26396136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer.
    Miyake T; Nakayama T; Naoi Y; Yamamoto N; Otani Y; Kim SJ; Shimazu K; Shimomura A; Maruyama N; Tamaki Y; Noguchi S
    Cancer Sci; 2012 May; 103(5):913-20. PubMed ID: 22320227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the GSTP1 c.313A>G variant to hearing loss risk in patients exposed to platin chemotherapy during childhood.
    Liberman PHP; Goffi-Gomez MVS; Schultz C; Jacob PL; de Paula CAA; Sartorato EL; Torrezan GT; Ferreira EN; Carraro DM
    Clin Transl Oncol; 2019 May; 21(5):630-635. PubMed ID: 30361796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.